We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.
- Authors
van den Bent, Martin J; Carpentier, Antoine F; Brandes, Alba A; Sanson, Marc; Taphoorn, Martin J B; Bernsen, Hans J J A; Frenay, Marc; Tijssen, Cees C; Grisold, Wolfgang; Sipos, Laslo; Haaxma-Reiche, Hanny; Kros, Johannes M; van Kouwenhoven, Mathilde C M; Vecht, Charles J; Allgeier, Anouk; Lacombe, Denis; Gorlia, Thierry
- Abstract
Anaplastic oligodendrogliomas are more responsive to chemotherapy than high-grade astrocytomas. We investigated, in a multicenter randomized controlled trial, whether adjuvant procarbazine, lomustine, and vincristine (PCV) chemotherapy improves overall survival (OS) in newly diagnosed patients with anaplastic oligodendrogliomas or anaplastic oligoastrocytomas.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 18, p2715
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.04.6078